KRAS and lung cancer: To assess the potency of BKA-073 in KRAS mutant-driven lung cancer, lox-stop-lox (LSL)-KRASG12D LKB1fl/fl (i.e. KL) mice were generated and bred out as previously described 30, 31, 50, 51.